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Abstract
The case illustrates the myriad of fulminating complications due to Clostridium difficile infection in a
previously healthy individual without any risk factors. Community acquired Clostridium difficile
infection can occur even many weeks after the course of broad spectrum antibiotics. There is no
definitive pattern or guidelines to predict who would develop the fulminating complications.
Case presentation
A previously fit 67-year-old, British, Caucasian retired
engineer was assisting in heavy manual labour when he
sustained a crush injury to his big toe. He had seen many
of these managed conservatively by the medical profession
before, so it was two weeks before he sought medical
assistance. He visited his general practioner (GP) when the
nail was lifting off, concerned that it may be infected. This
gentleman was admitted into hospital where the nail was
surgically removed and he was given a week’s course of
flucloxacillin. He attended emergency department every
other day to have the dressings changed and in time it
slowly healed.
Four to six weeks later he began to suffer from loose stools.
Again he managed this at home, initially with Imodium
and then with codeine from his GP. After about a week,
these agents failed to control his motions and he noted
that the odour was now more offensive. Stool cultures
were negative for Shigella, Salmonella, E. coli and Campy-
lobacter. He saw his GP again, and was now showing signs
of dehydration, so he was admitted to hospital, isolated
and put onto intravenous fluids andmetronidazole. Blood
tests demonstrated acute renal failure with systemic sepsis.
Four days later, stool cultures confirmed the presence of
Clostridium difficile. He was now opening his bowels every
half an hour day and night. Fluid resuscitation continued
and his abdominal plain films showed grossly dilated
loops of bowel. After a week, vancomycin and dietary
supplements were added and the team began to liase with
their surgical colleagues as his symptoms had not abated.
After twenty days he was so hypoalbuminaemic that his
peripheral oedema hampered peripheral access; therefore
nasogastric feeding was commenced. He continued to
deteriorate and the medical and surgical teams were
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concerned about that he had a persistent megacolon and
gross colonic oedema seen on sigmoidoscopy. After
considering the options carefully, a defunctioning ileost-
omy was created following a total colectomy, four weeks
after admission.
He came round from the operation with his left foot in
extreme pain. It was noted to be cool, dusky and have
inpalpable distal pulses and found to have an arterial clot.
This failed to improve and required a femoral-peroneal
bypass. His post-op recovery was further complicated by
the need for intensive dietary support as his pressure areas
began to ulcerate. His wounds were infected with MRSA,
but did not ulcerate. A month later, he noticed that his left
foot was cooler again. To his dismay the surgeons
confirmed that the graft had occluded and so he went on
to have a left below-knee amputation. This wound was
again complicated by MRSA infection. After time at a
community hospital he was discharged home, sixteen
weeks after admission with complete recovery and
followed up in the prosthetic clinic.
Clostridium difficile – The enemy within. Since 1977
Clostridium difficile has been recognised as the cause of
pseudomembranous colitis. The bacterium is an anaero-
bic, toxigenic, gram-positive rod. It produced spores which
can survive for months on surfaces, with many people
remaining asymptomatic carriers. The role of antibiotics in
disrupting normal bowel flora and therefore predisposing
to infection has been well described before.
Swift identification and then removal of precipitating
factors are the initial parts of treatment. Oral metronida-
zole or vancomycin alongside fluid and electrolyte
replacement is often enough to improve symptoms.
Patients who fail to respond need dietary supplemen-
tation, consideration of live yoghurts and withholding
Proton pump inhibitors and early surgical review. Despite
all this intervention, recurrence is common. This empha-
sises the current focus on initial prevention.
Discussion
Community acquired Clostridium difficile diarrhoea
(CACDD) is defined as diarrhoea developed outside
hospital settings. Although there is no universally agreed
definition for CACDD, various studies have taken various
criteria ranging from less than 72 hours to 6 months after
exposure to antibiotics [1,2]. However, CACDD can occur
in a individuals with no recent exposure to antibiotics
[3,5]. The community and hospital acquired infections are
both interlinked. Recent studies in Canada, USA and
Europe has showed CACDD is rising [6].Current trends
show the risk factors are also changing [7]. Clostridium
difficile infection in the UK causes an average increased
stay of 21 days and has an estimated cost of £4,000 per
case [8]. Fulminant CDAD is also increasing. It is a state of
clostridium difficile colitis not responsive to medical
therapy. It is complicated by leukocytosis (peripheral
white blood cell count >16 000/mm3), hypoalbumi-
nemia, renal failure and emergency colectomy and even
death.
This man initially had a mechanical injury to his toe and
now has a stoma and an amputation. He was originally
fourteen stone of muscle, able to lift a breezeblock with
one hand. At one stage of his rehabilitation, he struggled
to lift the bottle of Lucozade, which he was using as a
dumb-bell. This man was desperately unlucky to have such
an aggressive strain of C. Diff colitis, as he was not
immunocompromised and had no comorbidities. He
developed most of the recognised complications; surgery
prevented colonic perforation. The incidence of this is
increased by the use of anti-motility preparations, which
was his initial strategy in the community.
Antibiotic resistance and prescription cost reduction were
the drivers in teaching temperance in antibiotic use. The
risks of allergy and pseudomembranous colitis are also not
new phenomena. However Clostridium now is not
uniquely a disease of the elderly, no longer victimises
only the frail and the chronicity of antibiotic consumption
and symptoms can surprise the diagnostic.
His case is a reminder of our part in the butterfly effect:
Even the smallest of actions may have greater implications,
that were initially unforeseen.
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